https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Biologics/Biomaterials

Showing 65–79 of 79 results

Orthopedic Growth Factor Market Analysis | United States | 2019-2025 | MedCore

Growth factors are a group of small, soluble proteins that bind onto cell surface receptors, triggering a series of signals that regulate the body’s ability to grow, renew and heal. Due to the regenerative properties of growth factors, they have been exploited for bone healing in orthopedic applications. Since September 1, 2015, there are two main growth factor products offered in the U.S. market: INFUSE® by Medtronic and AUGMENT® by Wright Medical. Stryker’s OP-1™ which had been sold to Olympus Biotech is no longer available as Olympus Biotech ceased sales May 31, 2014. Stryker’s OP-1™ is a different form of bone morphogenic proteins (BMPs) that belong to a larger family of proteins called transforming growth factors.

more...

Spinal Machined Bone Allograft Market Analysis | United States | 2019-2025 | MedCore

Spinal fusion is a surgical procedure designed to combine two or more vertebrae together, eventually forming a fused bone. It is primarily used for eliminating or significantly reducing the pain caused by abnormal movement of the vertebrae by immobilizing them. Supplemental bone tissue, either autograft or allograft, is used for promoting bone growth. A union of two vertebral bodies is referred to as a single-level fusion. Fusion is accomplished by using either an instrumented or non-instrumented surgical approach. Instrumented fusions incorporate fixation devices to secure and stabilize the fusion site, and interbody devices are used for filling the intervertebral disc space to enhance and promote fusion. Non-instrumented fusions utilize bone tissue to promote growth, but do not incorporate any implant devices into the procedures.

more...

Dental Barrier Membranes Market Size, Share & COVID19 Impact Analysis | Argentina | 2021-2027 | MedCore | Segmented by: Type (Resorbable, Non-Resorbable), Material (Xenograft, Synthetic) & By Size (Small, Medium, Large)

Barrier membranes are a critical component to regeneration therapy and are aimed at restoring the form and function of the mouth. Commercially available on the market, barrier membranes function in dental surgeries to help retain bone grafting materials, to exclude epithelium and connective tissue from entering into sites of desired bone and ligament regeneration, or for the combination of these reasons. Whether restoring lost bone around teeth or implants, or in larger areas of the jaws affected by trauma or disease, too often there is inadequate gingival tissue to cover the membranes, leading to membrane exposure, extensive membrane contamination and procedural failure, which is unacceptable.

more...

Dental Barrier Membranes Market Size, Share & COVID19 Impact Analysis | Brazil | 2021-2027 | MedCore | Segmented by: Product (Emdogain®, GEM 21S®, Infuse™, Osteocel®)

Barrier membranes are a critical component to regeneration therapy and are aimed at restoring the form and function of the mouth. Commercially available on the market, barrier membranes function in dental surgeries to help retain bone grafting materials, to exclude epithelium and connective tissue from entering into sites of desired bone and ligament regeneration, or for the combination of these reasons. Whether restoring lost bone around teeth or implants, or in larger areas of the jaws affected by trauma or disease, too often there is inadequate gingival tissue to cover the membranes, leading to membrane exposure, extensive membrane contamination and procedural failure, which is unacceptable.

more...

Dental Barrier Membranes Market Size, Share & COVID19 Impact Analysis | Mexico | 2021-2027 | MedCore | Segmented by: Type (Resorbable, Non-Resorbable), Material (Xenograft, Synthetic) & By Size (Small, Medium, Large)

Barrier membranes are a critical component to regeneration therapy and are aimed at restoring the form and function of the mouth. Commercially available on the market, barrier membranes function in dental surgeries to help retain bone grafting materials, to exclude epithelium and connective tissue from entering into sites of desired bone and ligament regeneration, or for the combination of these reasons. Whether restoring lost bone around teeth or implants, or in larger areas of the jaws affected by trauma or disease, too often there is inadequate gingival tissue to cover the membranes, leading to membrane exposure, extensive membrane contamination and procedural failure, which is unacceptable.

more...

Dental Bone Graft Substitutes Procedure Volume Analysis | Europe | 2019-2025 | MedPro | Includes: Dental Implant Procedures Performed with Bone Grafts

The European market for dental biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes. The level of development of the dental implant market within a given country highly dictates the corresponding size and growth of the DBGS market within that region. As the patient demand for dental implant procedures increases, the potential number of cases that require a bone grafting procedure also increases. This in turn generates demand for dental bone graft substitutes, barrier membranes and the dental growth factor product, Emdogain®.

more...

Orthopedic Biomaterials Market Report Suite | Canada | 2016-2022 | MedSuite

Each of the three markets discussed in the report has a unique set of factors affecting its growth profile. In terms of the market drivers, for example, the bone graft market is seeing increasing adoption rate as newly trained surgeons are entering the workforce. The viscosupplementation market continues to bring improved products along with expanded indications. The bone stimulator market maintains a high clinical success rate and is therefore also increasing its adoption rate.

more...

Orthopedic Biomaterials Market Overview | Canada | 2016-2022 | MedView

Each of the three markets discussed in the report has a unique set of factors affecting its growth profile. In terms of the market drivers, for example, the bone graft market is seeing increasing adoption rate as newly trained surgeons are entering the workforce. The viscosupplementation market continues to bring improved products along with expanded indications. The bone stimulator market maintains a high clinical success rate and is therefore also increasing its adoption rate.

more...

Orthopedic Hyaluronic Acid Market Analysis | Canada | 2016-2022 | MedCore

One of the market limiters for the Canadian HA market is the reimbursement structure. None of the products are covered under standard healthcare plans and must be purchased directly or through extended healthcare coverage or private insurance. Thus, some patients opt out to receiving cortisone injections; these are reimbursed by standard healthcare and are a more affordable choice.
One of the factors that contributed positively to this market is ever expanding indication. The market originally started with treating osteoarthritis (OA) of the knee, since then some products expanded into hip, shoulder, a number of small joints, as well as assisting with post-surgery joint recovery.

more...

Spinal Bone Graft Substitutes Market Analysis | Canada | 2016-2022 | MedCore

Bone graft substitute products are utilized by dentists/periodontitis, neurosurgeons and orthopedic surgeons. Orthopedic indications represent the most major portion of the bone graft substitute market, with spinal fusions representing the most major category of surgery within that realm. For the purpose of this report, we do not assess the dental bone graft substitute market in any way. Instead, we focus on spinal indications for bone grafts and its size relative to the bone graft substitute market (excluding dental indications).

more...

Breast Tissue Markets and Breast Localization Wires Market Report Suite | United States | 2016-2022 | MedSuite

Growth will be driven by the aging U.S. population, increased mammogram procedure volume and improvement in mammogram quality. The rising volume of diagnoses will drive an increase in the number of patients requiring treatment, applying upward pressure to breast tissue marker unit sales and limiting the decline in breast localization wire unit sales over the forecast period.

more...

Breast Localization Wires Market Analysis | United States | 2016-2022 | MedCore

The value of the U.S. market for breast localization wires is expected to decline over the forecast period. Contraction will be driven by unit sales declines and reinforced by modest erosion in the ASP of breast localization wires.

more...

Breast Tissue Markers Market Analysis | United States | 2016-2022 | MedCore

The value of the U.S. breast tissue marker market is expected to increase modestly over the forecast period. Growth in the value of the market will be driven by increasing unit sales and limited by ASP erosion. The increasing incidence of breast cancer and utilization of breast tissue markers in percutaneous breast biopsies as well as axillary lymph node marking are expected to fuel unit sales growth over the next seven years. ASP erosion will be driven by commoditization of breast tissue markers with lower clinical value.

more...

Sacroiliac Joint Disorders and Fusion Market Analysis | United States | 2015-2021 | MedCore

Research findings included details on market sizing and trends, procedural data and competitive landscape, among other things. The research methodology and data collection for the analysis involved a multi-faceted approach which included: primary research, secondary research, utilization of iData’s proprietary in-house procedural database and an end-user physician online survey.

more...

Orthopedic Biomaterials, Bone Grafting and Hyaluronic Acid Viscosupplementation Market Report Suite | Asia-Pacific | 2011-2017 | MedSuite

The Asia-Pacific markets include Australia, China, Japan and South Korea. The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented into allografts, demineralized bone matrices and synthetics), hyaluronic acid (HA) viscosupplementation and bone morphogenetic protein (BMP) growth factor therapy. The market is approaching maturity, but is expected to continue to grow as a result of the aging Asia-Pacific population. BMP growth factor therapy was the fastest-growing segment in 2010, increasing almost 7% over the previous year.

more...